Cardiology in Review

Skip Navigation LinksHome > September/October 2004 - Volume 12 - Issue 5 > Atherosclerosis and Systemic Lupus Erythematosus
Cardiology in Review:
Review Article

Atherosclerosis and Systemic Lupus Erythematosus

Abusamieh, Mohammed MD; Ash, Julia MD

Collapse Box


Large increases in mortality related to premature atherosclerosis with coronary artery disease have been reported in patients with systemic lupus erythematosus (SLE). The current pathogenic hypothesis for atherosclerosis involves not only the classic factors identified in the Framingham study, but also includes chronic inflammation, corticosteroid therapy, excess of traditional risk factors, autoantibodies, immune complexes (containing antibodies to phospholipids, to oxidized low-density lipoproteins, and to endothelial cells), and cytokine-producing activated T cells. Early risk factor intervention and effective control of inflammation should be incorporated into the management of SLE to protect against atherosclerosis.

© 2004 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.